Baxter International Inc. vs. Daxor Corporation Common Stock
Baxter International Inc. (BAX) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| BAX | DXR | |
|---|---|---|
| Market Cap | $11.90 billion | $65.10 million |
| Revenue (TTM) | $11.47 billion | $1.45 million |
| Net Income (TTM) | $-1,063,000,000 | $-7,185,639 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | DXR | |
|---|---|---|
| Price / Book | 1.93 | 1.80 |
| Price / Sales | 1.04 | 45.01 |
BAX and DXR split the valuation factors evenly.
Profitability
| BAX | DXR | |
|---|---|---|
| Net Margin | -9.27% | -496.81% |
| Return on Equity | -17.20% | -19.84% |
BAX leads on 2 of 2 profitability factors.
Dividend
| BAX | DXR | |
|---|---|---|
| Dividend Yield | 0.18% | 0.27% |
DXR leads on 1 of 1 dividend factors.
Risk & Sentiment
| BAX | DXR | |
|---|---|---|
| Short Interest | 1.03% | 0.00% |
DXR leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, DXR overview, DXR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.